I think I see the issue here...
Simple example, company has 10 shares (and shareholders) valued on market at $1 each (which also happens to be cost). Business as usual, no changes to outlook etc, they issue another 100 shares to shareholders at 50c, adding $50 (ignore costs) to the balance sheet. Upon issue, and before the first trade of the day, the market cap is $60 or 54.5c per share, but before the first trade they have invested $6 each for 11 shares each, valued at 54.5c each.
I think what your saying is that with a cash injection of $180M the market cap will not move from $110M. Theoretically possible (especially if there is no furture value), but assuming nothing changes from today (exchange, IOP, sentiment etc) I would say highly unlikely. Before the first trade of the day (and ignoring costs), I would expect market cap to be $290M...i.e the average of shares on issue at final closing and the take up. WHither it goes from there, well I see two distinct arguments!
- Forums
- ASX - By Stock
- AGO
- Ann: Landmark Deal On Costs - Mining Back On
Ann: Landmark Deal On Costs - Mining Back On, page-62
-
-
- There are more pages in this discussion • 47 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AGO (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online